← 返回

口腔癌中 β-连环蛋白与肿瘤免疫微环境相关的预后意义

英文原题:Prognostic Significance of β-Catenin in Relation to the Tumor Immune Microenvironment in Oral Cancer.

查看英文原题

Prognostic Significance of β-Catenin in Relation to the Tumor Immune Microenvironment in Oral Cancer.

PubMed 2023/09/29(内容时间) Biomedicines Q2 · IF 4.5(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

本研究旨在探讨口腔鳞状细胞癌(OSCC)中β-连环蛋白表达的预后意义及其与肿瘤免疫微环境的关系。研究通过免疫组织化学检测125例OSCC患者标本中的β-连环蛋白和PD-L1表达,以及淋巴细胞和巨噬细胞密度。102例(81.6%)肿瘤检出膜性β-连环蛋白表达,2例(1.6%)检出核表达。β-连环蛋白表达与肿瘤及间质中的CD8+ T细胞浸润(TIL)以及肿瘤免疫微环境(TIME)类型相关。存在核β-连环蛋白的肿瘤与II型TIME相关,即PD-L1阴性且CD8+ TIL密度低的免疫忽视状态;而存在膜性β-连环蛋白表达的肿瘤则主要为IV型TIME,即PD-L1阴性但CD8+ TIL密度高的免疫耐受状态。间质CD8+ TIL高浸润与膜性β-连环蛋白表达同时存在时(但两者单独存在时并非如此),与更佳的疾病特异性生存独立相关(HR=0.48,p=0.019)。

综上,肿瘤中较高的间质CD8+ T细胞浸润与膜性β-连环蛋白表达相结合,可能成为预测OSCC患者生存改善的独立指标。

展开英文摘要原文

The aim of this study was to investigate the prognostic relevance of -catenin expression in oral squamous cell carcinoma (OSCC) and to explore relationships with the tumor immune microenvironment. Expression of -catenin and PD-L1, as well as lymphocyte and macrophage densities, were evaluated by immunohistochemistry in 125 OSCC patient specimens. Membranous -catenin expression was detected in 102 (81. 6%) and nuclear -catenin in 2 (1. 6%) tumors. There was an association between -catenin expression, tumoral, and stromal CD8 + T-cell infiltration (TIL) and also the type of tumor immune microenvironment (TIME).

Tumors harboring nuclear -catenin were associated with a type II TIME (i. e. , immune ignorance defined by a negative PD-L1 expression and low CD8 + TIL density), whereas tumors with membranous -catenin expression were predominantly type IV (i. e. , immune tolerance defined by negative PD-L1 and high CD8 + TIL density).

Combined, but not individual, high stromal CD8 + TILs and membranous -catenin expression was independently associated with better disease-specific survival (HR = 0. 48, p = 0. 019). Taken together, a combination of high stromal CD8 + T-cell infiltration and membranous -catenin in the tumor emerges as an independent predictor of better survival in OSCC patients.

论文信息

作者
Lequerica-Fernández P、Rodríguez-Santamarta T、García-García E、Blanco-Lorenzo V、Torres-Rivas HE、Rodrigo JP、Suárez-Sánchez FJ、García-Pedrero JM
第一作者单位
Department of Biochemistry, Hospital Universitario Central de Asturias (HUCA), Carretera de Rubín, 33011 Oviedo, Spain.Spain
通讯作者单位
Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Instituto Universitario de Oncología del Principado de Asturias (IUOPA), Universidad de Oviedo, Carretera de Rubín, 33011 Oviedo, Spain.Spain
期刊
Biomedicines2023 Sep 29
原文标识
PubMed 37893049 · DOI 10.3390/biomedicines11102675